Chiesi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHIESI, and what generic alternatives to CHIESI drugs are available?
CHIESI has fifteen approved drugs.
There are forty-eight US patents protecting CHIESI drugs.
There are three hundred and four patent family members on CHIESI drugs in forty-one countries and fifty-three supplementary protection certificates in eighteen countries.
Summary for Chiesi
| International Patents: | 304 |
| US Patents: | 48 |
| Tradenames: | 16 |
| Ingredients: | 10 |
| NDAs: | 15 |
| Patent Litigation for Chiesi: | See patent lawsuits for Chiesi |
Drugs and US Patents for Chiesi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiesi | KENGREAL | cangrelor | POWDER;INTRAVENOUS | 204958-001 | Jun 22, 2015 | RX | Yes | Yes | 9,700,575 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-004 | Apr 23, 2015 | RX | Yes | No | 10,016,404 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-002 | Dec 21, 2012 | RX | Yes | No | 10,016,404 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chiesi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Chiesi | FERRIPROX | deferiprone | SOLUTION;ORAL | 208030-002 | Apr 20, 2018 | 7,049,328 | ⤷ Try a Trial |
| Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-005 | Apr 23, 2015 | 5,712,279 | ⤷ Try a Trial |
| Chiesi | CARDENE | nicardipine hydrochloride | CAPSULE;ORAL | 019488-001 | Dec 21, 1988 | 3,985,758 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHIESI drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Inhalation Solution | 300 mg/4 mL | ➤ Subscribe | 2017-08-31 |
| ➤ Subscribe | Injection | 0.1 mg/mL, 200 mL and0.2mg/mL, 200 mL | ➤ Subscribe | 2013-06-20 |
| ➤ Subscribe | Tablets | 500 mg | ➤ Subscribe | 2016-01-29 |
| ➤ Subscribe | Injection | 2.5 mg/mL, 10 mL Ampoules | ➤ Subscribe | 2006-12-27 |
International Patents for Chiesi Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2650922 | ⤷ Try a Trial |
| Denmark | 1725234 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2009140407 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chiesi Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1758555 | 16C1003 | France | ⤷ Try a Trial | PRODUCT NAME: BETULINE; REGISTRATION NO/DATE: EU/1/15/1069 20160118 |
| 1725234 | 2/2014 | Austria | ⤷ Try a Trial | PRODUCT NAME: LOMITAPID BZW. DESSEN PHARMAZEUTISCH ANNEHMBARE SALZE; REGISTRATION NO/DATE: EU/1/13/851/001-EU/1/13/851/003 20130731 |
| 1758555 | PA2016023,C1758555 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: BERZO ZIEVES EKSTRAKTAS; REGISTRATION NO/DATE: EU/1/15/1069/001 20160114 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
